New Mechanistic Insights Into Nobiletin's Protective Effects Against LPS-Induced Hyperinflammatory Acute Lung Injury in Rats: Targeting miR-200, AT1R/p38 MAPK, and HMGB1/NF-κB mTOR Pathways.

El-Shaer RAA, Ibrahim S, AbuoHashish NA, Eltokhy AK, Ghanem HB, Ibrahim RR, Hewady PM, El-Deeb OS, Farghal EE, Eissa R, Shalaby MM, Awad MM

Open source

DOI
10.1155/omcl/3253224
Published
2026
Container
Oxidative medicine and cellular longevity
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/omcl/3253224,
  title = {New Mechanistic Insights Into Nobiletin's Protective Effects Against LPS-Induced Hyperinflammatory Acute Lung Injury in Rats: Targeting miR-200, AT1R/p38 MAPK, and HMGB1/NF-κB mTOR Pathways.},
  author = {El-Shaer RAA and Ibrahim S and AbuoHashish NA and Eltokhy AK and Ghanem HB and Ibrahim RR and Hewady PM and El-Deeb OS and Farghal EE and Eissa R and Shalaby MM and Awad MM},
  year = {2026},
  journal = {Oxidative medicine and cellular longevity},
  doi = {10.1155/omcl/3253224},
  url = {https://doi.org/10.1155/omcl/3253224}
}

RIS

TY  - JOUR
TI  - New Mechanistic Insights Into Nobiletin's Protective Effects Against LPS-Induced Hyperinflammatory Acute Lung Injury in Rats: Targeting miR-200, AT1R/p38 MAPK, and HMGB1/NF-κB mTOR Pathways.
AU  - El-Shaer RAA
AU  - Ibrahim S
AU  - AbuoHashish NA
AU  - Eltokhy AK
AU  - Ghanem HB
AU  - Ibrahim RR
AU  - Hewady PM
AU  - El-Deeb OS
AU  - Farghal EE
AU  - Eissa R
AU  - Shalaby MM
AU  - Awad MM
PY  - 2026
JO  - Oxidative medicine and cellular longevity
DO  - 10.1155/omcl/3253224
UR  - https://doi.org/10.1155/omcl/3253224
ER  - 

APA

RAA, E., S, I., NA, A., AK, E., HB, G., RR, I., PM, H., OS, E., EE, F., R, E., MM, S., & MM, A. (2026). New Mechanistic Insights Into Nobiletin's Protective Effects Against LPS-Induced Hyperinflammatory Acute Lung Injury in Rats: Targeting miR-200, AT1R/p38 MAPK, and HMGB1/NF-κB mTOR Pathways.. Oxidative medicine and cellular longevity. https://doi.org/10.1155/omcl/3253224

Source records